SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-040193
Filing Date
2022-02-14
Accepted
2022-02-14 10:20:04
Documents
2
Group Members
NESTLE S.A.SOCIETE DES PRODUITS NESTLE S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d318517dsc13g.htm SC 13G 67166
2 EX-99.I d318517dex99i.htm EX-99.I 4870
  Complete submission text file 0001193125-22-040193.txt   73736
Mailing Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203
Business Address C/O NESTLE USA, INC. 800 NORTH BRAND BLVD. GLENDALE CA 91203 (818) 548-7050
Nestle Health Science US Holdings, Inc. (Filed by) CIK: 0001644164 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121
Business Address 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 (858) 200-7888
Prometheus Biosciences, Inc. (Subject) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92364 | Film No.: 22626711
SIC: 2834 Pharmaceutical Preparations